메뉴 건너뛰기




Volumn 2013, Issue 6, 2013, Pages

Creatine for treating muscle disorders

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; PLACEBO;

EID: 84891697839     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004760.pub4     Document Type: Review
Times cited : (55)

References (93)
  • 1
    • 77952959405 scopus 로고    scopus 로고
    • Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study
    • PUBMED: 20395096]
    • Banerjee B, Sharma U, Balasubramanian K, Kalaivani M, Kalra V, Jagannathan NR. Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. Magnetic Resonance Imaging 2010;28(5):698-707. [PUBMED: 20395096]
    • (2010) Magnetic Resonance Imaging , vol.28 , Issue.5 , pp. 698-707
    • Banerjee, B.1    Sharma, U.2    Balasubramanian, K.3    Kalaivani, M.4    Kalra, V.5    Jagannathan, N.R.6
  • 2
    • 34248589200 scopus 로고    scopus 로고
    • Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial
    • PUBMED: 17471547]
    • Chung YL, Alexanderson H, Pipitone N, Morrison C, Dastmalchi M, Stahl-Hallengren C, et al.Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial. Arthritis and Rheumatism 2007;57(4):694-702. [PUBMED: 17471547]
    • (2007) Arthritis and Rheumatism , vol.57 , Issue.4 , pp. 694-702
    • Chung, Y.L.1    Alexanderson, H.2    Pipitone, N.3    Morrison, C.4    Dastmalchi, M.5    Stahl-Hallengren, C.6
  • 3
    • 21844474016 scopus 로고    scopus 로고
    • CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy
    • PUBMED: 15984021]
    • Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, et al.CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy. Annals of Neurology 2005;58(1):151-5. [PUBMED: 15984021]
    • (2005) Annals of Neurology , vol.58 , Issue.1 , pp. 151-155
    • Escolar, D.M.1    Buyse, G.2    Henricson, E.3    Leshner, R.4    Florence, J.5    Mayhew, J.6
  • 4
    • 0034642154 scopus 로고    scopus 로고
    • A placebo-controlled crossover trial of creatine in mitochondrial diseases
    • PUBMED: 11113239]
    • Klopstock T, Querner V, Schmidt F, Gekeler F, Walter M, Hartard M, et al.A placebo-controlled crossover trial of creatine in mitochondrial diseases. Neurology 2000;55(11):1748-51. [PUBMED: 11113239]
    • (2000) Neurology , vol.55 , Issue.11 , pp. 1748-1751
    • Klopstock, T.1    Querner, V.2    Schmidt, F.3    Gekeler, F.4    Walter, M.5    Hartard, M.6
  • 5
    • 20144387513 scopus 로고    scopus 로고
    • Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS cross-over study
    • PUBMED: 15804248]
    • Kornblum C, Schröder R, Müller K, Vorgerd M, Eggers J, Bogdanow M, et al.Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS cross-over study. European Journal of Neurology 2005;12(4):300-9. [PUBMED: 15804248]
    • (2005) European Journal of Neurology , vol.12 , Issue.4 , pp. 300-309
    • Kornblum, C.1    Schröder, R.2    Müller, K.3    Vorgerd, M.4    Eggers, J.5    Bogdanow, M.6
  • 7
    • 0037432120 scopus 로고    scopus 로고
    • Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy
    • PUBMED: 12578937]
    • Schneider-Gold C, Beck M, Wessig C, George A, Kele H, Reiners K, et al.Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy. Neurology 2003;60(3):500-2. [PUBMED: 12578937]
    • (2003) Neurology , vol.60 , Issue.3 , pp. 500-502
    • Schneider-Gold, C.1    Beck, M.2    Wessig, C.3    George, A.4    Kele, H.5    Reiners, K.6
  • 8
    • 0030731246 scopus 로고    scopus 로고
    • A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies
    • PUBMED: 9390662]
    • Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle and Nerve 1997;20(12):1502-9. [PUBMED: 9390662]
    • (1997) Muscle and Nerve , vol.20 , Issue.12 , pp. 1502-1509
    • Tarnopolsky, M.A.1    Roy, B.D.2    MacDonald, J.R.3
  • 9
    • 2442697688 scopus 로고    scopus 로고
    • Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy
    • PUBMED: 15159476]
    • Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty TJ, Roy BD, et al.Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 2004;62(10):1771-7. [PUBMED: 15159476]
    • (2004) Neurology , vol.62 , Issue.10 , pp. 1771-1777
    • Tarnopolsky, M.A.1    Mahoney, D.J.2    Vajsar, J.3    Rodriguez, C.4    Doherty, T.J.5    Roy, B.D.6
  • 10
    • 0347991959 scopus 로고    scopus 로고
    • Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1
    • PUBMED: 14694498]
    • Tarnopolsky M, Mahoney D, Thompson T, Naylor H, Doherty TJ. Creatine monohydrate supplementation does not increase muscle strength, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1. Muscle and Nerve 2004;29(1):51-8. [PUBMED: 14694498]
    • (2004) Muscle and Nerve , vol.29 , Issue.1 , pp. 51-58
    • Tarnopolsky, M.1    Mahoney, D.2    Thompson, T.3    Naylor, H.4    Doherty, T.J.5
  • 11
    • 0033924202 scopus 로고    scopus 로고
    • Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled cross-over trial
    • PUBMED: 10891977]
    • Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, et al.Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled cross-over trial. Archives of Neurology 2000;57(7):956-63. [PUBMED: 10891977]
    • (2000) Archives of Neurology , vol.57 , Issue.7 , pp. 956-963
    • Vorgerd, M.1    Grehl, T.2    Jager, M.3    Muller, K.4    Freitag, G.5    Patzold, T.6
  • 12
    • 0036144373 scopus 로고    scopus 로고
    • Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled cross-over study
    • PUBMED: 11790236]
    • Vorgerd M, Zange J, Kley R, Grehl T, Husing A, Jager M, et al.Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled cross-over study. Archives of Neurology 2002;59(1):97-101. [PUBMED: 11790236]
    • (2002) Archives of Neurology , vol.59 , Issue.1 , pp. 97-101
    • Vorgerd, M.1    Zange, J.2    Kley, R.3    Grehl, T.4    Husing, A.5    Jager, M.6
  • 13
    • 0343022262 scopus 로고    scopus 로고
    • Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
    • PUBMED: 10802796]
    • Walter MC, Lochmuller H, Reilich P, Klopstock T, Huber R, Hartard M, et al.Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology 2000;54(9):1848-50. [PUBMED: 10802796]
    • (2000) Neurology , vol.54 , Issue.9 , pp. 1848-1850
    • Walter, M.C.1    Lochmuller, H.2    Reilich, P.3    Klopstock, T.4    Huber, R.5    Hartard, M.6
  • 14
    • 0344407002 scopus 로고    scopus 로고
    • Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study
    • PUBMED: 12529796]
    • Walter MC, Reilich P, Lochmuller H, Kohnen R, Schlotter B, Hautmann H, et al.Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study. Journal of Neurology 2002;249(12):1717-22. [PUBMED: 12529796]
    • (2002) Journal of Neurology , vol.249 , Issue.12 , pp. 1717-1722
    • Walter, M.C.1    Reilich, P.2    Lochmuller, H.3    Kohnen, R.4    Schlotter, B.5    Hautmann, H.6
  • 15
    • 0036347518 scopus 로고    scopus 로고
    • Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy
    • PUBMED: 1220074]
    • Barisic N, Bernert G, Ipsiroglu O, Stromberger C, Muller T, Gruber S, et al.Effects of oral creatine supplementation in a patient with MELAS phenotype and associated nephropathy. Neuropediatrics 2002;33(3):157-61. [PUBMED: 1220074]
    • (2002) Neuropediatrics , vol.33 , Issue.3 , pp. 157-161
    • Barisic, N.1    Bernert, G.2    Ipsiroglu, O.3    Stromberger, C.4    Muller, T.5    Gruber, S.6
  • 17
    • 0032859505 scopus 로고    scopus 로고
    • Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies
    • Borchert A, Wilichowski E, Hanefeld F. Supplementation with creatine monohydrate in children with mitochondrial encephalomyopathies. Muscle and Nerve 1999;22(9):1299-300.
    • (1999) Muscle and Nerve , vol.22 , Issue.9 , pp. 1299-1300
    • Borchert, A.1    Wilichowski, E.2    Hanefeld, F.3
  • 19
    • 0034111130 scopus 로고    scopus 로고
    • Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study
    • Felber S, Skladal D, Wyss M, Kremser C, Koller A, Sperl W. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study. Neurological Research 2000;22(2):145-50.
    • (2000) Neurological Research , vol.22 , Issue.2 , pp. 145-150
    • Felber, S.1    Skladal, D.2    Wyss, M.3    Kremser, C.4    Koller, A.5    Sperl, W.6
  • 20
    • 0018805044 scopus 로고
    • Phosphocreatinine in myotonic dystrophy (Steinerts disease)
    • Freddi A, Paci A, DeCiantis R, Lancia G, DeSantis L. Phosphocreatinine in myotonic dystrophy (Steinerts disease). Lancet 1979;1(8131):1400-1.
    • (1979) Lancet , vol.1 , Issue.8131 , pp. 1400-1401
    • Freddi, A.1    Paci, A.2    DeCiantis, R.3    Lancia, G.4    DeSantis, L.5
  • 25
    • 85048487210 scopus 로고    scopus 로고
    • Lack of detectable effect of creatine supplementation on skeletal muscle or cardiac function in Duchenne muscular dystrophy
    • Sejersen T, Hovmoller M, Hok L, Nordmark-Andersson E, Winberg P, Nylander E, et al.Lack of detectable effect of creatine supplementation on skeletal muscle or cardiac function in Duchenne muscular dystrophy. Neuromuscular Disorders 2000;10:375.
    • (2000) Neuromuscular Disorders , vol.10 , pp. 375
    • Sejersen, T.1    Hovmoller, M.2    Hok, L.3    Nordmark-Andersson, E.4    Winberg, P.5    Nylander, E.6
  • 27
    • 0033541016 scopus 로고    scopus 로고
    • Creatine monohydrate increases strength in patients with neuromuscular disease
    • Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999;52(4):854-7.
    • (1999) Neurology , vol.52 , Issue.4 , pp. 854-857
    • Tarnopolsky, M.1    Martin, J.2
  • 28
    • 1842425028 scopus 로고    scopus 로고
    • Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation
    • Tarnopolsky MA, Simon DK, Roy BD, Chorneyko K, Lowther SA, Johns DR, et al.Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation. Muscle and Nerve 2004;29(4):537-47.
    • (2004) Muscle and Nerve , vol.29 , Issue.4 , pp. 537-547
    • Tarnopolsky, M.A.1    Simon, D.K.2    Roy, B.D.3    Chorneyko, K.4    Lowther, S.A.5    Johns, D.R.6
  • 29
    • 85048509398 scopus 로고    scopus 로고
    • Creatine supplementation in pediatric rheumatology
    • (accessed 26 April 2013)
    • NCT01217320. Creatine supplementation in pediatric rheumatology. http://www.clinicaltrials.gov/ct2/show/NCT01217320 (accessed 26 April 2013).
  • 31
    • 0037240189 scopus 로고    scopus 로고
    • Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults
    • Brose A, Parise G, Tarnopolsky MA. Creatine supplementation enhances isometric strength and body composition improvements following strength exercise training in older adults. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 2003;58(1):11-9.
    • (2003) Journals of Gerontology. Series B, Psychological Sciences and Social Sciences , vol.58 , Issue.1 , pp. 11-19
    • Brose, A.1    Parise, G.2    Tarnopolsky, M.A.3
  • 38
    • 0032852064 scopus 로고    scopus 로고
    • Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
    • Dechent P, Pouwels PJ, Wilken B, Hanefeld F, Frahm J. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. American Journal of Physiology 1999;277(3 Pt 2):R698-704.
    • (1999) American Journal of Physiology , vol.277 , Issue.3 , pp. R698-R704
    • Dechent, P.1    Pouwels, P.J.2    Wilken, B.3    Hanefeld, F.4    Frahm, J.5
  • 39
    • 0038115294 scopus 로고    scopus 로고
    • Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice
    • Dedeoglu A, Kubilus JK, Yang L, Ferrante KL, Hersch SM, Beal MF, et al.Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice. Journal of Neurochemistry 2003;85(6):1359-67.
    • (2003) Journal of Neurochemistry , vol.85 , Issue.6 , pp. 1359-1367
    • Dedeoglu, A.1    Kubilus, J.K.2    Yang, L.3    Ferrante, K.L.4    Hersch, S.M.5    Beal, M.F.6
  • 40
    • 38949116663 scopus 로고    scopus 로고
    • Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle
    • Deldicque L, Atherton P, Patel R, Theisen D, Nielens H, Rennie MJ, Francaux M. Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. Journal of Applied Physiology 2008;104(2):371-8.
    • (2008) Journal of Applied Physiology , vol.104 , Issue.2 , pp. 371-378
    • Deldicque, L.1    Atherton, P.2    Patel, R.3    Theisen, D.4    Nielens, H.5    Rennie, M.J.6    Francaux, M.7
  • 41
    • 0035942323 scopus 로고    scopus 로고
    • A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy
    • PUBMED: 11320181]
    • Fenichel GM, Griggs RC, Kissel J, Kramer TI, Mendell JR, Moxley RT, et al.A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology 2001;56(8):1075-9. [PUBMED: 11320181]
    • (2001) Neurology , vol.56 , Issue.8 , pp. 1075-1079
    • Fenichel, G.M.1    Griggs, R.C.2    Kissel, J.3    Kramer, T.I.4    Mendell, J.R.5    Moxley, R.T.6
  • 46
    • 0027537622 scopus 로고
    • A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression
    • Guimbal C, Kilimann MW. A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. Journal of Biological Chemistry 1993;268(12):8418-21.
    • (1993) Journal of Biological Chemistry , vol.268 , Issue.12 , pp. 8418-8421
    • Guimbal, C.1    Kilimann, M.W.2
  • 47
    • 0028360971 scopus 로고
    • Cloning and sequencing of rat kidney L-arginine: glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine
    • Guthmiller P, van Pilsum JF, Boen JR, McGuire DM. Cloning and sequencing of rat kidney L-arginine: glycine amidinotransferase. Studies on the mechanism of regulation by growth hormone and creatine. Journal of Biological Chemistry 1994;269(26):17556-60.
    • (1994) Journal of Biological Chemistry , vol.269 , Issue.26 , pp. 17556-17560
    • Guthmiller, P.1    van Pilsum, J.F.2    Boen, J.R.3    McGuire, D.M.4
  • 48
    • 0026722343 scopus 로고
    • Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
    • Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clinical Science 1992;83(3):367-74.
    • (1992) Clinical Science , vol.83 , Issue.3 , pp. 367-374
    • Harris, R.C.1    Soderlund, K.2    Hultman, E.3
  • 49
    • 33644927838 scopus 로고    scopus 로고
    • Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG
    • Hersch SM, Gevorkian S, Marder K, Moskowitz C, Feigin A, Cox M, et al.Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG. Neurology 2006;66(2):250-2.
    • (2006) Neurology , vol.66 , Issue.2 , pp. 250-252
    • Hersch, S.M.1    Gevorkian, S.2    Marder, K.3    Moskowitz, C.4    Feigin, A.5    Cox, M.6
  • 50
    • 70049099036 scopus 로고    scopus 로고
    • Assessing risk of bias in included studies
    • In: Higgins JPT, Green S (editors) Version 5.1.0 (updated March 2011)
    • Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
    • (2011) Cochrane Handbook for Systematic Reviews of Interventions
    • Higgins, J.P.T.1    Altman, D.G.2    Sterne, J.A.C.3
  • 56
    • 0034737380 scopus 로고    scopus 로고
    • Neuroprotective effects of creatine administration against NMDA and malonate toxicity
    • Malcon C, Kaddurah-Daouk R, Beal MF. Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Research 2000;860(1-2):195-8.
    • (2000) Brain Research , vol.860 , Issue.1-2 , pp. 195-198
    • Malcon, C.1    Kaddurah-Daouk, R.2    Beal, M.F.3
  • 58
    • 0025641352 scopus 로고
    • Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies
    • Matthews PM, Arnold DL. Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies. Annals of Neurology 1990;28(6):839-40.
    • (1990) Annals of Neurology , vol.28 , Issue.6 , pp. 839-840
    • Matthews, P.M.1    Arnold, D.L.2
  • 59
    • 0025968255 scopus 로고
    • In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease
    • Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 1991;41(1):114-20.
    • (1991) Neurology , vol.41 , Issue.1 , pp. 114-120
    • Matthews, P.M.1    Allaire, C.2    Shoubridge, E.A.3    Karpati, G.4    Carpenter, S.5    Arnold, D.L.6
  • 61
    • 0033952218 scopus 로고    scopus 로고
    • Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women
    • Mihic S, MacDonald JR, McKenzie S, Tarnopolsky MA. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. Medicine and Science in Sports and Exercise 2000;32(2):291-6.
    • (2000) Medicine and Science in Sports and Exercise , vol.32 , Issue.2 , pp. 291-296
    • Mihic, S.1    MacDonald, J.R.2    McKenzie, S.3    Tarnopolsky, M.A.4
  • 62
    • 0034875340 scopus 로고    scopus 로고
    • Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis
    • Parise G, Mihic S, MacLennan D, Yarasheski KE, Tarnopolsky MA. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. Journal of Applied Physiology 2001;91(3):1041-7.
    • (2001) Journal of Applied Physiology , vol.91 , Issue.3 , pp. 1041-1047
    • Parise, G.1    Mihic, S.2    MacLennan, D.3    Yarasheski, K.E.4    Tarnopolsky, M.A.5
  • 63
    • 0028210487 scopus 로고
    • Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis
    • Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR, et al.Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis and Rheumatism 1994;37(5):736-46.
    • (1994) Arthritis and Rheumatism , vol.37 , Issue.5 , pp. 736-746
    • Park, J.H.1    Vital, T.L.2    Ryder, N.M.3    Hernanz-Schulman, M.4    Partain, C.L.5    Price, R.R.6
  • 64
    • 0028797784 scopus 로고
    • Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis
    • Park JH, Olsen NJ, King L, Jr, Vital T, Buse R, Kari S, et al.Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis. Arthritis and Rheumatism 1995;38(1):68-77.
    • (1995) Arthritis and Rheumatism , vol.38 , Issue.1 , pp. 68-77
    • Park, J.H.1    Olsen, N.J.2    King, L.3    Vital, T.4    Buse, R.5    Kari, S.6
  • 65
    • 0036133699 scopus 로고    scopus 로고
    • Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice
    • Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, Wallimann T, et al.Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscular Disorders 2002;12(2):172-82.
    • (2002) Neuromuscular Disorders , vol.12 , Issue.2 , pp. 172-182
    • Passaquin, A.C.1    Renard, M.2    Kay, L.3    Challet, C.4    Mokhtarian, A.5    Wallimann, T.6
  • 67
    • 0032840508 scopus 로고    scopus 로고
    • Long-term oral creatine supplementation does not impair renal function in healthy athletes
    • Poortmans JR, Francaux M. Long-term oral creatine supplementation does not impair renal function in healthy athletes. Medicine and Science in Sports and Exercise 1999;31(8):1108-10.
    • (1999) Medicine and Science in Sports and Exercise , vol.31 , Issue.8 , pp. 1108-1110
    • Poortmans, J.R.1    Francaux, M.2
  • 68
    • 0033826998 scopus 로고    scopus 로고
    • Adverse effects of creatine supplementation: fact or fiction?
    • [PUBMED: 10999421]
    • Poortmans JR, Francaux M. Adverse effects of creatine supplementation: fact or fiction?. Sports Medicine 2000;30(3):155-70. [PUBMED: 10999421]
    • (2000) Sports Medicine , vol.30 , Issue.3 , pp. 155-170
    • Poortmans, J.R.1    Francaux, M.2
  • 70
    • 0031788804 scopus 로고    scopus 로고
    • Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells
    • Pulido SM, Passaquin AC, Leijendekker WJ, Challet C, Wallimann T, Ruegg UT. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Letters 1998;439(3):357-62.
    • (1998) FEBS Letters , vol.439 , Issue.3 , pp. 357-362
    • Pulido, S.M.1    Passaquin, A.C.2    Leijendekker, W.J.3    Challet, C.4    Wallimann, T.5    Ruegg, U.T.6
  • 72
    • 79960705415 scopus 로고    scopus 로고
    • Review Manager (RevMan)
    • 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration,
    • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
    • (2012)
  • 73
    • 3843080877 scopus 로고    scopus 로고
    • Drug treatment for facioscapulohumeral muscular dystrophy
    • Rose MR, Tawil R. Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD002276.pub2]
    • (2004) Cochrane Database of Systematic Reviews , Issue.2
    • Rose, M.R.1    Tawil, R.2
  • 74
    • 1842854849 scopus 로고    scopus 로고
    • Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats
    • Roy BD, Bourgeois JM, Mahoney DJ, Tarnopolsky MA. Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats. Canadian Journal of Physiology and Pharmacology 2002;80(10):1008-14.
    • (2002) Canadian Journal of Physiology and Pharmacology , vol.80 , Issue.10 , pp. 1008-1014
    • Roy, B.D.1    Bourgeois, J.M.2    Mahoney, D.J.3    Tarnopolsky, M.A.4
  • 75
    • 38749090555 scopus 로고    scopus 로고
    • Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation
    • Safdar A, Yardley NJ, Snow R, Melov S, Tarnopolsky MA. Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation. Physiological Genomics 2008;32:219-28.
    • (2008) Physiological Genomics , vol.32 , pp. 219-228
    • Safdar, A.1    Yardley, N.J.2    Snow, R.3    Melov, S.4    Tarnopolsky, M.A.5
  • 76
    • 0019948028 scopus 로고
    • Quantitation of muscle function in children: a prospective study in duchenne muscular dystrophy
    • Scott OM, Hyde SA, Goddard C, Dubowitz V. Quantitation of muscle function in children: a prospective study in duchenne muscular dystrophy. Muscle and Nerve 1982;5(4):291-301.
    • (1982) Muscle and Nerve , vol.5 , Issue.4 , pp. 291-301
    • Scott, O.M.1    Hyde, S.A.2    Goddard, C.3    Dubowitz, V.4
  • 79
    • 0027159872 scopus 로고
    • Treatment of inclusion-body myositis with high-dose intravenous immunglobulin
    • Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunglobulin. Neurology 1993;43(5):876-9.
    • (1993) Neurology , vol.43 , Issue.5 , pp. 876-879
    • Soueidan, S.A.1    Dalakas, M.C.2
  • 81
    • 0032822221 scopus 로고    scopus 로고
    • Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease
    • Tarnopolsky MA, Parise G. Direct measurement of high-energy phosphate compounds in patients with neuromuscular disease. Muscle and Nerve 1999;22(9):1228-33.
    • (1999) Muscle and Nerve , vol.22 , Issue.9 , pp. 1228-1233
    • Tarnopolsky, M.A.1    Parise, G.2
  • 82
    • 0033541016 scopus 로고    scopus 로고
    • Creatine monohydrate increases strength in patients with neuromuscular disease
    • Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999;52(4):854-7.
    • (1999) Neurology , vol.52 , Issue.4 , pp. 854-857
    • Tarnopolsky, M.1    Martin, J.2
  • 84
    • 0035031453 scopus 로고    scopus 로고
    • Creatine transporter and mitochondrial creatine kinase protein content in myopathies
    • Tarnopolsky MA, Parshad A, Walzei B, Schlattner U, Wallimann T. Creatine transporter and mitochondrial creatine kinase protein content in myopathies. Muscle & Nerve 2001;24(5):682-8.
    • (2001) Muscle & Nerve , vol.24 , Issue.5 , pp. 682-688
    • Tarnopolsky, M.A.1    Parshad, A.2    Walzei, B.3    Schlattner, U.4    Wallimann, T.5
  • 87
  • 88
    • 0031786712 scopus 로고    scopus 로고
    • The therapeutic potential of oral creatine supplementation in muscle disease
    • PUBMED: 9824841]
    • Wyss M, Felber S, Skladal D, Koller A, Kremser C, Sperl W. The therapeutic potential of oral creatine supplementation in muscle disease. Medical Hypotheses 1998;51(4):333-6. [PUBMED: 9824841]
    • (1998) Medical Hypotheses , vol.51 , Issue.4 , pp. 333-336
    • Wyss, M.1    Felber, S.2    Skladal, D.3    Koller, A.4    Kremser, C.5    Sperl, W.6
  • 89
    • 0033935979 scopus 로고    scopus 로고
    • Creatine and creatinine metabolism
    • [PUBMED: 10893433]
    • Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiological Reviews 2000;80(3):1107-213. [PUBMED: 10893433]
    • (2000) Physiological Reviews , vol.80 , Issue.3 , pp. 1107-1213
    • Wyss, M.1    Kaddurah-Daouk, R.2
  • 90
    • 3042796442 scopus 로고    scopus 로고
    • Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice
    • Zhu S, Li M, Figueroa BE, Liu A, Stavrovskaya IG, Pasinelli P, et al.Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. Journal of Neuroscience 2004;24(26):5909-12.
    • (2004) Journal of Neuroscience , vol.24 , Issue.26 , pp. 5909-5912
    • Zhu, S.1    Li, M.2    Figueroa, B.E.3    Liu, A.4    Stavrovskaya, I.G.5    Pasinelli, P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.